What is the recommended dose of cephalexin (cephalosporin) for treating cellulitis in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin Dosing for Cellulitis

For adults with uncomplicated cellulitis, cephalexin 500 mg orally four times daily (every 6 hours) for 5 days is the recommended regimen, extending treatment only if clinical improvement has not occurred within this timeframe. 1, 2, 3

Standard Adult Dosing

  • The FDA-approved dosing for skin and soft tissue infections is 250 mg every 6 hours, with 500 mg every 12 hours as an alternative for less severe infections. 3
  • However, current IDSA guidelines specifically recommend cephalexin 500 mg every 6 hours (four times daily) as the standard regimen for cellulitis. 1
  • The total daily dose ranges from 1-4 grams per day, divided into multiple doses. 3

Treatment Duration

  • The standard treatment duration is 5 days if clinical improvement has occurred, with extension only if symptoms have not improved within this initial period. 2
  • Traditional 7-14 day courses are no longer necessary for uncomplicated cases. 1, 2
  • This shorter duration is supported by randomized controlled trial data showing no difference in outcomes between 5 and 10 days of therapy. 1

When Cephalexin is Appropriate

  • Cephalexin is first-line therapy for typical nonpurulent cellulitis without abscess, purulent drainage, or penetrating trauma. 2
  • Beta-lactam monotherapy (including cephalexin) is successful in 96% of cellulitis cases, confirming that MRSA coverage is usually unnecessary. 2
  • Do not add MRSA coverage (such as TMP-SMX) to cephalexin for pure cellulitis without purulent features—combination therapy provides no additional benefit. 2

When NOT to Use Cephalexin Alone

  • Cellulitis associated with purulent drainage, abscess, penetrating trauma, or MRSA risk factors requires either clindamycin monotherapy OR combination therapy with cephalexin plus TMP-SMX or doxycycline. 2
  • Cephalexin lacks activity against MRSA and should not be used as monotherapy when MRSA coverage is indicated. 2

Pediatric Dosing

  • The usual pediatric dose is 25-50 mg/kg/day divided into doses every 6 hours. 3
  • For streptococcal pharyngitis and skin infections in children over 1 year, the total daily dose may be divided and given every 12 hours. 3
  • For severe infections, the pediatric dosage may be doubled. 3

High-Dose Considerations

  • Emerging evidence suggests high-dose cephalexin (1000 mg four times daily) may reduce treatment failure rates (3.2% vs 12.9% with standard dosing), though with more minor adverse effects. 4
  • However, this high-dose regimen is not yet guideline-recommended and should be reserved for cases where standard dosing has failed or for particularly severe presentations. 4

Special Populations

  • In morbidly obese patients (BMI ≥40 kg/m²), standard cephalexin dosing appears adequate—therapeutic failure rates do not differ significantly from non-obese patients (20% vs 14.5%). 5
  • Empiric dose adjustment based solely on BMI is not necessary. 5

Critical Pitfalls to Avoid

  • Never use cephalexin for cellulitis with purulent drainage or abscess without adding MRSA coverage—this is a common error that leads to treatment failure. 2
  • Do not reflexively extend treatment beyond 5 days without reassessing clinical response—longer courses are unnecessary for uncomplicated cases. 2
  • Cephalexin has no activity against Pasteurella multocida (animal bites) or Eikenella corrodens (human bites)—use amoxicillin-clavulanate instead. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis.

Journal of clinical pharmacy and therapeutics, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.